Baird Financial Group, Inc. Karyopharm Therapeutics Inc. Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

A detailed history of Baird Financial Group, Inc. transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 37,800 shares of KPTI stock, worth $29,484. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,800

Previous 36,800 2.72%

Holding current value

$29,484

Previous $32,000 3.13%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.7 - $1.06 $700 - $1,060	1,000 Added 2.72%	37,800 $31,000
Q2 2024 Aug 13, 2024	BUY	$0.87 - $1.58 $13,920 - $25,280	16,000 Added 76.92%	36,800 $32,000
Q1 2024 May 14, 2024	BUY	$0.72 - $1.66 $5,040 - $11,620	7,000 Added 50.72%	20,800 $31,000
Q2 2023 Aug 11, 2023	SELL	$1.79 - $4.59 $23,583 - $60,473	-13,175 Reduced 48.84%	13,800 $24,000
Q1 2023 May 15, 2023	BUY	$2.84 - $3.92 $22,362 - $30,866	7,874 Added 41.22%	26,975 $104,000
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $5,173 - $7,379	1,268 Added 7.49%	18,191 $99,000
Q2 2022 Aug 08, 2022	SELL	$4.15 - $8.37 $473 - $954	-114 Reduced 0.67%	16,923 $76,000
Q1 2022 May 13, 2022	SELL	$5.91 - $14.38 $16,429 - $39,976	-2,780 Reduced 14.03%	17,037 $126,000
Q4 2021 Feb 09, 2022	BUY	$5.21 - $8.61 $11,133 - $18,399	2,137 Added 12.09%	19,817 $127,000
Q3 2021 Nov 12, 2021	BUY	$4.45 - $10.63 $3,177 - $7,589	714 Added 4.21%	17,680 $103,000
Q2 2021 Aug 11, 2021	BUY	$8.11 - $11.11 $10,932 - $14,976	1,348 Added 8.63%	16,966 $175,000
Q1 2021 May 13, 2021	BUY	$9.85 - $17.69 $2,029 - $3,644	206 Added 1.34%	15,618 $164,000
Q4 2020 Feb 11, 2021	BUY	$14.15 - $17.19 $19,357 - $23,515	1,368 Added 9.74%	15,412 $239,000
Q3 2020 Nov 12, 2020	BUY	$14.14 - $19.71 $9,403 - $13,107	665 Added 4.97%	14,044 $205,000
Q2 2020 Oct 22, 2020	SELL	$16.6 - $25.25 $1,328 - $2,020	-80 Reduced 0.59%	13,379 $253,000
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $8,582 - $13,054	517 Added 3.99%	13,459 $258,000
Q1 2020 May 14, 2020	SELL	$14.38 - $27.72 $963 - $1,857	-67 Reduced 0.52%	12,942 $249,000
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $120,073 - $255,887	13,009 New	13,009 $249,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $62.2M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Karyopharm Therapeutics Inc. Transaction History